Key facts
- This page summarizes Eric M. Dube's Form 4 filing for Travere Therapeutics, Inc. (TVTX).
- 14 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 17 Sep 2026, 21:31.
Eric M. Dube - 15 Sep 2026 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)
- Reporting relationship
- CHIEF EXECUTIVE OFFICER, Director
- Issuer ticker
- TVTX
- Reported as of
- 15 Sep 2026
- Net transaction value
- -$25,390,729
- SEC form
- 4
- Accepted by SEC
- 17 Sep 2026, 21:31:33 UTC
- Prior SEC filing
- 06 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Elizabeth E. Reed, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Eric M. Dube filed Form 4 for Travere Therapeutics, Inc. (TVTX) on 17 Sep 2026.
Change
- Previous filing in this sequence was filed on 06 May 2026.
- Current net transaction value: -$25,390,729.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001763494
Primary reporting owner
Dube Eric M
- Relationship
- CHIEF EXECUTIVE OFFICER, Director
- Address
- C/O TRAVERE THERAPEUTICS, INC., 3611 VALLEY CENTRE DR., SUITE 300, SAN DIEGO
- Signature
- /s/ Elizabeth E. Reed, Attorney-in-Fact
- Signature date
- 17 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TVTX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +95,666
- Change %
- +22%
- Price
- $23.34*
- Shares after
- 528,552
- Date
- 15 Sep 2026
- Ownership
- Direct
TVTX
transaction
Common Stock
Sale
- Transaction value
- $3,936,527
- Shares
- -63,498
- Change %
- -12%
- Price
- $61.99
- Shares after
- 465,054
- Date
- 15 Sep 2026
- Ownership
- Direct
- Footnotes
- F1, F2
TVTX
transaction
Common Stock
Sale
- Transaction value
- $1,804,222
- Shares
- -28,796
- Change %
- -6.2%
- Price
- $62.66
- Shares after
- 436,258
- Date
- 15 Sep 2026
- Ownership
- Direct
- Footnotes
- F1, F3
TVTX
transaction
Common Stock
Sale
- Transaction value
- $197,422
- Shares
- -3,102
- Change %
- -0.71%
- Price
- $63.64
- Shares after
- 433,156
- Date
- 15 Sep 2026
- Ownership
- Direct
- Footnotes
- F1, F4
TVTX
transaction
Common Stock
Sale
- Transaction value
- $17,634
- Shares
- -270
- Change %
- -0.06%
- Price
- $65.31
- Shares after
- 432,886
- Date
- 15 Sep 2026
- Ownership
- Direct
- Footnotes
- F1
TVTX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +195,841
- Change %
- +45%
- Price
- $23.34*
- Shares after
- 628,727
- Date
- 16 Sep 2026
- Ownership
- Direct
TVTX
transaction
Common Stock
Sale
- Transaction value
- $6,307,964
- Shares
- -99,716
- Change %
- -16%
- Price
- $63.26
- Shares after
- 529,011
- Date
- 16 Sep 2026
- Ownership
- Direct
- Footnotes
- F1, F5
TVTX
transaction
Common Stock
Sale
- Transaction value
- $6,117,289
- Shares
- -96,125
- Change %
- -18%
- Price
- $63.64
- Shares after
- 432,886
- Date
- 16 Sep 2026
- Ownership
- Direct
- Footnotes
- F1, F6
TVTX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +108,493
- Change %
- +25%
- Price
- $23.34*
- Shares after
- 541,379
- Date
- 17 Sep 2026
- Ownership
- Direct
TVTX
transaction
Common Stock
Sale
- Transaction value
- $6,567,876
- Shares
- -101,691
- Change %
- -19%
- Price
- $64.59
- Shares after
- 439,688
- Date
- 17 Sep 2026
- Ownership
- Direct
- Footnotes
- F1, F7
TVTX
transaction
Common Stock
Sale
- Transaction value
- $441,795
- Shares
- -6,802
- Change %
- -1.5%
- Price
- $64.95
- Shares after
- 432,886
- Date
- 17 Sep 2026
- Ownership
- Direct
- Footnotes
- F1, F8
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TVTX
transaction
Derivative
Employee stock option (right to buy)
Options Exercise
- Transaction value
- Shares
- -95,666
- Change %
- -24%
- Price
- $0.000000*
- Shares after
- 304,334
- Date
- 15 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 95,666
- Exercise price
- $23.34
- Footnotes
- F9
TVTX
transaction
Derivative
Employee stock option (right to buy)
Options Exercise
- Transaction value
- Shares
- -195,841
- Change %
- -64%
- Price
- $0.000000*
- Shares after
- 108,493
- Date
- 16 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 195,841
- Exercise price
- $23.34
- Footnotes
- F9
TVTX
transaction
Derivative
Employee stock option (right to buy)
Options Exercise
- Transaction value
- Shares
- -108,493
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 17 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 108,493
- Exercise price
- $23.34
- Footnotes
- F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 9 footnotes
Footnote F1
This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
Footnote F2
The weighted average sale price for the transaction reported was $61.9945, and the range of prices were between $61.405 and $62.40. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Footnote F3
The weighted average sale price for the transaction reported was $62.6553, and the range of prices were between $62.41 and $63.35. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Footnote F4
The weighted average sale price for the transaction reported was $63.6434, and the range of prices were between $63.45 and $63.97. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Footnote F5
The weighted average sale price for the transaction reported was $63.2593, and the range of prices were between $62.51 and $63.505. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Footnote F6
The weighted average sale price for the transaction reported was $63.6389, and the range of prices were between $63.51 and $64.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Footnote F7
The weighted average sale price for the transaction reported was $64.5866, and the range of prices were between $63.84 and $64.83. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Footnote F8
The weighted average sale price for the transaction reported was $64.9508, and the range of prices were between $64.84 and $65.14. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Footnote F9
The stock option is fully vested and exercisable.